Clinical Trial Update: Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating alpha-2 agonists for sedation in critically ill patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University of Edinburgh | Conditions: Critical Illness | Phase 3 | Status: COMPLETED